NextGen Healthcare Reports Fiscal 2022 Third Quarter Results
Raises Fiscal 2022 Financial Guidance ATLANTA--(BUSINESS WIRE)--NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, today announced...
Day: January 25, 2022
Abivax 2022 Financial Communication Calendar
PARIS, FRANCE / ACCESSWIRE / January 25, 2022 / Abivax SA (Euronext Paris: FR0012333284 - ABVX), a clinical-stage biotechnology company...
West Island Closes on 1st Tranche of Private Placement
Toronto, Ontario--(Newsfile Corp. - January 25, 2022) - West Island Brands Inc. (CSE: WIB) (FSE: 39N0) (OTCQB: WIBFF) ("West Island"...
AgeTech Startup, AskAnnie.ai, Is Launching a Voice-First Digital Assistant for Home Health and Home Care
Chicago, Illinois--(Newsfile Corp. - January 25, 2022) - A Chicago-based startup is launching a voice-first digital assistance platform that will...
Atlas Health Raises $40M Series A to Expand AI-Powered Patient Advocacy Solution
Investment in philanthropic medical financial aid solution empowers hospitals and health systems to help more patients access and afford care...
AIROS Medical and Fist Assist Devices, LLC Announce Launch of Commercial Website for Fist Assist FA-1 Wearable Medical Device
LAS VEGAS--(BUSINESS WIRE)--AIROS Medical, Inc., a designer, manufacturer, and distributor of compression therapy devices, and Fist Assist Devices, LLC (Fist...
Neuropathix, Inc. Welcomes Daniele Piomelli, PhD, MD to the Company’s Scientific Advisory Board
DOYLESTOWN, PA / ACCESSWIRE / January 25, 2022 / Neuropathix, Inc. ("Neuropathix" or the "Company") (OTCQB:NPTX), a socially responsible pain...
Jupiter Wellness Announces Board Approval of $5.0 Million Share Buyback Program
Represents Approximately 30% of Jupiter Wellness's Outstanding Shares at current market priceJUPITER, FL / ACCESSWIRE / January 25, 2022 /...
Chiesi USA Announces New Publication of Post Hoc Analysis on Timing of Ischemic Events in Cardiac Patients and Role of KENGREAL® (cangrelor) in Reducing Risk
Post hoc analysis of the CHAMPION PHOENIX clinical trial demonstrates that the majority of ischemic events occurred early in percutaneous...
Rakovina Therapeutics President to Join Expert Panel at the Fifth Annual DDR, ATR & PARP Inhibitors Summit
VANCOUVER, British Columbia, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV:RKV) (“the Company”), a biopharmaceutical company committed to...
INmune Bio, Inc. Announces Research Collaboration with Chinese University of Hong Kong to Evaluate INKmune in Nasopharyngeal Cancer
Boca Raton, Florida, Jan. 25, 2022 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (“INMB” or “the Company”), a clinical-stage immunology company...
HEXO Provides Update on “The Path Forward”; Maintains #1 Position in Canada and Announces Redecan Product and Market Expansion
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated May 11, 2021...
HMNC Brain Health Expands International Patent Portfolio with Two Stress-axis Related Substances for Major Depressive Disorder
In-Licensing arrangement with the renowned Max Planck Society, extends patent protection for clinical research and strengthens Nelivabon and Cortibon developmental...
ORIC Pharmaceuticals Announces Regulatory Clearance of Clinical Trial Application for ORIC-114 in Advanced Solid Tumors with EGFR or HER2 Exon 20 Alterations or HER2 Amplifications
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Jan. 25, 2022 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical...
Yield10 Bioscience Hires Darren Greenfield as Senior Director of Seed Operations
WOBURN, Mass., Jan. 25, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced the hiring...
Immunovant Appoints Mark Levine as Chief Legal Officer
Mr. Levine adds valuable experience to the leadership team as Immunovant accelerates the development of batoclimab with the expected initiation...
Biomea Fusion Announces First Patient Dosed
BMF-219 is the first irreversible covalent menin inhibitor to enter the clinicPhase I trial is enrolling patients with relapsed/refractory acute...
Trinity Biotech Announces That Its Shareholders Have Approved All of the Four Resolutions That Were the Subject of the EGM Held on January 25, 2022
DUBLIN, Ireland, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic...
Outlook Therapeutics Provides a Corporate Update and Business Outlook
Outlook Therapeutics advancing first ever ophthalmic formulation of bevacizumab towards new U.S. FDA Biologics License Application (BLA) submission, anticipated this...
CinDome Pharma announces successful completion of thorough QT study of CIN-102 (deudomperidone) in healthy subjects.
CIN-102, Deudomperidone, is a novel, deuterium-containing, peripherally selective dopamine (D2/D3) receptor antagonist.Study demonstrated that therapeutic and ~5-fold supra-therapeutic concentrations of...